Stay updated on SafetyEfficacyLDXADHDAdultsClinicalTrial
Sign up to get notified when there's something new on the SafetyEfficacyLDXADHDAdultsClinicalTrial page.

Latest updates to the SafetyEfficacyLDXADHDAdultsClinicalTrial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check64 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a detailed study on Lisdexamfetamine Dimesylate (LDX) for ADHD, including inclusion and exclusion criteria, which may impact the understanding of the study's scope and methodology.SummaryDifference18%
- Check71 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check107 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to SafetyEfficacyLDXADHDAdultsClinicalTrial
Enter your email address, and we'll notify you when there's something new on the SafetyEfficacyLDXADHDAdultsClinicalTrial page.